Indo is the leading Spanish independent manufacturer of ophthalmic lenses and distributor of medical equipment for the eye care sector.
Apheon’s investment thesis was rooted in acquiring the leading independent optical lens manufacturer in Spain and Morocco. Indo counts with a heritage brand in a resilient and profitable market underpinned by structural demographic drivers (ageing population) coupled with healthy supply dynamics. During our investment period, we partnered with a strong and committed management team that pushed Indo to (i) outgrow the market in Spain and Morocco, gaining meaningful market share across the Mediterranean region; (ii) build a completely new R&D department, having launched several blockbuster products during Apheon’s tenure; and (iii) further invest in and optimize the company’s industrial footprint, unlocking meaningful efficiencies and transforming its two premises in Spain and Morocco in sector-leading state-of-the-art facilities.
Spain
Healthcare; Niche Industrials
Our manifesto: contributing to the development of sustainable finance
To succeed with this strategy, Apheon believes a holistic and collective approach is fundamental.
Holistic: it is essential that all aspects of ESG are equally and continuously supported. This is why we are active at every stage of the investment cycle by applying proprietarily developed methodologies and initiatives which are built on 5 priorities covering the broad ESG spectrum: